Are pharmacists reducing COPD’S impact through smoking cessation and assessing inhaled steroid use?

About this item

Title

Are pharmacists reducing COPD’S impact through smoking cessation and assessing inhaled steroid use?

Content partner

University of Otago

Collection

Otago University Research Archive

Description

The National Institute for Health and Clinical Excellence (NICE) COPD 2004 guidelines recommend: ∗ COPD patients who smoke should be encouraged to stop at every opportunity; ∗ Inhaled corticosteroid should be used only among patients with moderate to severe COPD; ∗ Pharmacists should identify smokers and provide smoking cessation advice. The community pharmacy contract requires pharmacists to review patients’ medications, creating an opportunity for reviewing the prescribing of inhaled cortic...

Read more

Format

Research paper

Research format

Scholarly text / Journal article

Thesis level

Article

Date created

2012-02-01

Creator

Verma, Arpana / Harrison, Annie / Torun, Perihan / Vestbo, Jørgen / Edwards, Richard / Thornton, Judith

URL

https://hdl.handle.net/10523/32223

Related subjects

COPD / Inhaled steroids / Medicines use review / NICE / Pharmacists / Smoking cessation

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.